A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech n Beijing September 24, 2020. — Reuters pic

KUALA LUMPUR, Jan 12 — Malaysia Pharmaniaga Bhd has signed an agreement with China’s Sinovac to purchase ready-to-fill Covid-19 vaccines and later to manufacture the vaccine domestically, it said on Tuesday.

Pharmaniaga said in a filing to the bourse that the company will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how.

“This will also help Pharmaniaga in long-term partnerships, including technology transfer to grow the sector in Malaysia,” the company said.

Malaysia has been in talks to secure a total of 23.9 million doses of Covid-19 vaccines from Sinovac and another Chinese manufacturer CanSino Biologics, and from Russia’s Gamaleya Institute, the maker of the Sputnik V vaccine.

The Southeast Asian nation has also procured coronavirus vaccines from U.S. and German drugmakers Pfizer and BioNTech, as well as British-Swedish biopharmaceutical firm AstraZeneca PLC. — Reuters


Similar articles:

  1. Egypt to get COVID-19 vaccines from GAVI alliance within weeks [https://middle-east-online.com/en/egypt-get-covid-19-vaccines-gavi-alliance-within-weeks]
  2. Malaysia’s Pharmaniaga signs COVID vaccine agreement with China’s Sinovac [https://www.todayonline.com/world/malaysias-pharmaniaga-signs-covid-vaccine-agreement-chinas-sinovac]

Leave a Reply

Your email address will not be published. Required fields are marked *